NKTR
Nektar Therapeutics
Price:  
1.17 
USD
Volume:  
2,200,588.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

NKTR WACC - Weighted Average Cost of Capital

The WACC of Nektar Therapeutics (NKTR) is 8.1%.

The Cost of Equity of Nektar Therapeutics (NKTR) is 11.15%.
The Cost of Debt of Nektar Therapeutics (NKTR) is 5.00%.

Range Selected
Cost of equity 8.40% - 13.90% 11.15%
Tax rate 0.10% - 0.10% 0.10%
Cost of debt 5.00% - 5.00% 5.00%
WACC 6.7% - 9.5% 8.1%
WACC

NKTR WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.99 1.62
Additional risk adjustments 0.0% 0.5%
Cost of equity 8.40% 13.90%
Tax rate 0.10% 0.10%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 6.7% 9.5%
Selected WACC 8.1%